Aggressive chemotherapy of leukemia increases the risk of study, we observed raised sICAM-1 plasma levels associated severe infections during treatment-induced myelosuppression.
violation of sampling protocol, one due to impaired liver function (bilirubin Ͼ30 mol/l) of the patient.
During the neutropenic period, patients were nursed under Introduction conditions of reverse isolation with physical examination at least daily, and oral amphotericin B and ciprofloxacin (AML) As more aggressive chemotherapy is employed to increase the or sulfamethoxazole-trimethoprim/colistin (ALL) were given rate of remissions in acute leukemia, serious infectious comfor infection prevention. Patients also had routine surveillance plications associated with neutropenia have emerged as a cultures of nose, throat and stool. Chest radiographs were major source of morbidity and mortality. In neutropenia, obtained at least weekly until discharge. High resolution CT infections of the respiratory tract and septicemia account for scans were performed in three patients with clinically susthe majority of all documented infections.
1 However, the fever pected pulmonary infection but normal X-ray. During neutrothat occurs during neutropenia is frequently unexplained, penia, parenteral antibacterial therapy was started when fever often referred to as fever of unknown origin (FUO), or may be (у38.5°C) developed which was not related to blood products induced by transfusion of blood products and drug regimens. or drugs. If fever persisted for 3 days and no bacterial agent Neutropenic patients often have an inadequate inflammatory was detectable, empirical antibacterial therapy was changed response to infections. Fever may be the only clinical finding, and systemic amphotericin B was administered. while other classical signs of inflammation are still absent. Thus, in pneumonia, crepitations and pulmonary infiltrations may be minimal or delayed.
Sample collection
Adhesion molecules such as E-selectin (CD62e), intercellular adhesion molecule 1 (ICAM-1, CD54) and vascular cell Sample collection was started prior to (n = 43) or within the adhesion molecule 1 (VCAM-1, CD106) have been implicated first 3 days of cytostatic treatment (n = 5), thereafter at intervals in the pathogenesis of inflammatory responses by regulating of three times a week until discharge of the patient. When leukocyte-endothelial cell interactions.
3-5
Whereas profever developed, five samples were obtained on a daily schedinflammatory cytokines induce E-selectin and VCAM-1 ule. In most cases blood samples were drawn from a central expression preferentially on endothelial cells, cytokinevenous catheter (Raaf). Blood was collected at a pre-set time induced ICAM-1 expression has demonstrated a broad tissue between 8 and 9 am in ethylenediamine tetra-acetic acid distribution.
6-8 Increased plasma levels of circulating adhesion (EDTA), and was centrifuged at 3000 g for 15 min within 2 h. molecules (CAMs) have been shown in untreated acute leukePlasma was stored at −70°C until analysis. Prestudy evaluation mia 9,10 and were found during severe pulmonary infections or confirmed that receptor concentrations were stable in whole septicemia in non-neutropenic patients.
11,12 In a preliminary blood at room temperature for at least 6 h before separation of plasma. C-reactive protein (CRP) was determined from serum milligrams/liter was indicated as the upper limit of the referthree categories: Group 1: patients with pneumonia (PN). This ence range for CRP in the serum of healthy adults.
group consisted of patients with clinically suspected pneumonia confirmed by pulmonary infiltrates in X-ray or CT scan evaluated by independent radiologists. This group included Classification of febrile episodes two patients diagnosed as relapse of fungal pneumonia based on clinical findings and residual pulmonary infiltrates. Group Febrile episode was defined as axillary temperature readings 2: patients with proven infection (IN) except pneumonia. у38.5°C on 2 consecutive days. Patients who became febrile These patients had microbiologically proven infections while their absolute white blood cell counts (WBC) were (positive blood cultures) or significant elevation of virus titers Ͻ1 × 10 9 /l or fell to this level within 48 h were analyzed (clinically defined infection) but had normal chest radiograph within the neutropenic group. When fever developed blood and no clinical signs of pneumonia. Bacteremia with coagucultures were obtained from a peripheral vein, and from each lase-negative staphylococci were considered as proven infeccatheter lumen if the patient had an indwelling intravenous tion only if the infectious agent could be isolated repeatedly. catheter. Patients also had cultures taken from throat, urine, Group 3: patients with fever of unknown origin (FUO). stool and from clinically suspected sites of infection prior to Patients were categorized as having FUO when clinical and parenteral antibacterial therapy.
microbiological examination failed to ascertain infectious According to clinical and microbiological surveillance, etiology. patients with fever during neutropenia were stratified into Immunoassays Results sE-selectin, sVCAM-1 and sICAM-1 plasma concentrations were determined by commercially available enzyme-linked Forty-eight courses in 32 patients (27 AML, five ALL) were available for evaluation. Forty-two treatment courses were immunosorbent assays. Assays for sE-selectin and sVCAM-1 (British Bio-technology, Oxford, UK) were obtained from Bierapplied in newly diagnosed leukemia (29 × remission induction, 13 × consolidation), six courses were given for remission mann (Bad Nauheim, Germany), sICAM-1 assay (Bender MedSystems, Vienna, Austria) was purchased from Medgenix induction in relapse (Table 1) . Ten courses were uneventful, while 38 treatment courses (Ratingen, Germany). Measurements were generally performed according to the manufacturer's instructions. The Ewere complicated by 43 febrile episodes, 35 of which occurred during neutropenia. Fifteen patients were classified selectin assay was modified for analysis of EDTA plasma samples in that heparin-sodium was added to the sample clinically as having pneumonia (PN), six patients had proven infection but normal X-ray (IN), and 14 had fever of unknown dilution buffer in a final concentration of 125 IU/ml to prevent clot formation.
origin (FUO). In six of 15 patients (40%) the etiology of pneumonia was confirmed microbiologically by blood cultures or bronchoalveolar lavage. In four additional patients (26.6%) pneumonia was ascertained histologically by lung biopsy or Statistical analysis on autopsy but in three of these no etiological agent was identified. Significant microbiologic and histologic findings For comparison of differences in individual patients the Wilcoxon's test for paired samples was used. Patient groups were are depicted in Table 2 . Pneumonia was assumed to be of fungal origin in eight cases, non-fungal in seven cases. From compared with the Mann-Whitney U-test. To calculate increases in CAMs, levels at admission were compared with four patients who died during hospitalization, three had histological signs of pneumonia at autopsy, one patient died due peak levels of CAMs obtained during the subsequent febrile episode while WBC were Ͻ1 × 10 9 /l. Time delay between to progressive leukemia. In the IN group five patients had bacteremia. Either the indwelling catheter or the upper respiratory increases of sICAM-1 and appearance of pulmonary infiltrates was evaluated by the Kendall Rank correlation coefficient.
tract could be ascertained as the source of bacteremia in three sICAM-1 levels than patients without signs of pneumonia (median 860 (range 530-2140) vs 590 g/l (range 390-920), P = 0.0007). Plasma levels of sICAM-1 obtained at admission were not significantly different in both groups.
An increase of sICAM-1 plasma concentrations of more than 300 g/l above baseline obtained at admission (chosen as an arbitrary cutoff value) failed to identify pneumonia during neutropenia in only one out of 15 patients (sensitivity 0.93, specificity 0.9, positive predictive value 0.87, negative predictive value 0.94) (Figure 2) . Similar elevations of sICAM-1 levels were found in only two of 20 febrile patients not suffering from pneumonia.
In our series, C-reactive protein (CRP) was regularly increased during neutropenic fever (CRP Ͼ100 mg/l in 30 out of 35 events). Measurement of CRP was not useful either to confirm or to rule out pneumonia in neutropenic fever (CRP Ͼ 100 (Ͼ200 mg/l): sensitivity 0.93 (0.73), specificity 0.2 (0.35), positive predictive value 0.46 (0.61), negative predictive value 0.8 (0.76)).
Studies of time delay between sICAM-1 levels and radiographic infiltrates revealed that first day with increases of sICAM-1 (50% above baseline levels) paralleled radiographic evidence of pneumonia in most patients (Figure 3 ). Correlation was significant when analyzed with the Kendall Rank correlation coefficient (P = 0.045). In pneumonia, sICAM-1 elevation was usually prolonged and persisted for days or weeks, even after defervescence of the patients (Figure 1a ).
Discussion
The etiology of fever in neutropenic patients is difficult to ascertain. When microbiological surveillance failed to prove infectious origin, CRP has been reported to discriminate between fever of bacterial and non-bacterial origin. 18 How- patients. None of the patients progressed to septic shock requiring intensive care support. In all patients, levels of CAMs (sICAM-1, sVCAM-1 and sEselectin) were consistently detectable throughout the neutropenic period. sE-selectin and sVCAM-1 levels did not increase significantly, neither in pneumonia nor in other febrile episodes, during chemotherapy-induced neutropenia. Moreover, when compared to baseline levels obtained at admission, plasma levels of sE-selectin and sVCAM-1 were significantly reduced at leukocyte nadir independent of febrile complications (sE-selectin: median 43 (range 12-486) vs 19 g/l (range 10-278), P Ͻ 0.0001; sVCAM-1: 1140 (range 450-3580) vs 970 g/l (460-4170), P = 0.0006). A typical time course of CAMs illustrates a continuous decrease particularly of sE-selectin following chemotherapy-induced leukocyte depletion (Figure 1) .
In contrast, no leukocyte-dependent changes were observed for sICAM-1 (baseline: median 460 g/l (range 160-580) vs leukocyte nadir: 440 g/l (range 180-870), P = 0.9). Levels of sICAM-1 molecules were elevated in 15 patients during pneumonia as compared to levels obtained at admission (median
Figure 3
Time delay between the number of days after start of 860 (range 530-2140) vs 460 g/l (range 160-580), chemotherapy until sICAM-1 plasma levels increased to more than P = 0.0001). Plasma levels of sICAM-1 were similar in patients 50% above baseline (y-axis) and first appearance of pulmonary infilwith fungal and non-fungal pneumonia (P = 0.9). Patients with
trates (x-axis) in 13 neutropenic patients with newly diagnosed pneumonia (proven by X-ray (n = 12) or high-resolution CT scan (n = 1).
neutropenic fever due to pneumonia had significantly higher penia including most fever phases classified as FUO. Monitorselectin and sVCAM-1 found at leukocyte nadir support the hypothesis that circulating leukocytes contribute to plasma ing plasma concentrations of CAMs during neutropenic fever showed a positive correlation of sICAM-1 with clinically levels of sE-selectin and sVCAM-1 in vivo, probably by means of leukocyte-endothelial cell interactions. Recently, defined pneumonia. Significantly elevated sICAM-1 levels were present in 14 of 15 patients with pneumonia, whereas decreased E-selectin and increased sICAM-1 levels have been found during bacterial infections in neutropenic patients. 32 only two of 20 febrile episodes not related to pneumonia were accompanied by comparable sICAM-1 increases. Thus, elevUnfortunately, the overall extent of pulmonary involvement was not stated. In our study increases of sICAM-1 were higher ation of sICAM-1 plasma levels appears to be a marker with high specificity and sensitivity for pneumonia during neutroin pneumonia, even in those of fungal origin, when compared with the small group of patients with bacteremia without pulpenia. In our hands, elevations of sICAM-1 paralleled changes in X-ray. sICAM-1 increases were sustained and persisted even monary infiltrates. after patients became afebrile. Therefore, during neutropenia, increase of sICAM-1 in pneumonia is not a short-lived event which may be missed by infrequent determinations.
